论文部分内容阅读
白血病免疫特征欧洲研究小组(EGIL)提出了急性白血病免疫学分型准则。按免疫学特征将急性白血病分为:①急性淋巴细胞白血病(ALL);②急性髓细胞白血病(AML);③双表型急性白血病(BAL);④未分化的急性白血病。 ALL主要分为B细胞系和T细胞系两人类:B细胞系至少表达CD_(19)、CD_(79(?))(mb-1)或CD_(22)三种早期B细胞分化抗原中的二种。B-ALL又分为四类:即B-Ⅰ(前前B)ALL;B-Ⅱ(普通)ALL;B-Ⅲ(前-B)ALL;B-Ⅳ(成熟)BALL;B-Ⅰ ALL除上述三种抗原外无其他B细胞抗原表达;B-Ⅱ ALL中CD_(10)~+ B-Ⅲ ALL胞浆IgM~+;B-Ⅳ根据表面免疫球蛋白(smlg)来确定,或
The European Study Group on Leukemia Immunity (EGIL) proposed guidelines for immunophenotyping of acute leukemia. According to the immunological characteristics of acute leukemia are divided into: 1 acute lymphoblastic leukemia (ALL); 2 acute myeloid leukemia (AML); 3 double phenotype acute leukemia (BAL); 4 undifferentiated acute leukemia. ALL is mainly divided into B and T cell lines: B cells express at least CD_(19), CD_(79(?))(mb-1), or CD_(22) three early B cell differentiation antigens. Two kinds. B-ALL is divided into four categories: B-I (pre-ante-B) ALL; B-II (general) ALL; B-III (pre-B) ALL; B-IV (mature) BALL; No other B cell antigens were expressed except the above three antigens; CD_(10)~+ B-III ALL cytoplasmic IgM~+ in B-II ALL; B-IV was determined based on surface immunoglobulin (smlg), or